Our study showed better results in terms of primary and longterm closure compared to many previous studies. This can perhaps be attributed to the better socio-economic conditions of the patients and to the reduced exposure to active and passive smoking within society. While difficult to prove with certainty the use of areolar tissue has significant advantages theoretically and we feel its use could have been an important aspect in the overall success rate of TM repair in our series. To prove this definitively however remains a more daunting task. We had no specific control group for comparison and there were multivariable considerations that could have also influenced TM closure rates. As such the limits of this study are acknowledged and there is a general plead for further prospectivecontrolled studies to prove this hypothesis. Further clarity would require multi-variant analysis taking into account the technical skills of the surgeon, the approach, the anaesthetic provided, the status of the middle ear, the functional status of the eustachian tube, the health of the contralateral ear, the size and location of the perforation, the graft material, the use of other ancillary measures (pegging techniques, various tissue glues), whether infection occurred postoperatively, primary VS revision surgery.
| MATERIALS AND METHODS

| Ethical considerations
None.
| Patients
A retrospective case series was undertaken. Patients who had received bone conduction hearing devices (BCHDs) were identified from a prospectively maintained database of paediatric cases (<18 years at first fitting), performed over a 10-year period (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) .
A total of 180 consecutive paediatric surgical cases were reviewed.
A total of 22 patients (15%) were identified who had undergone 32 primary surgical BCHI procedures for COM hearing rehabilitation.
Data on primary indication were unavailable for 34 of 180 cases. In the remaining 146 cases, the main indications for receiving BCHDsboth implants and soft-band devices-included persistent otitis media with effusion (40%), single-sided loss (multiple causes-20%) and congenital anomalies (25%). A total of 64% of patients were female (M:F, 8:14), and two had associated Down syndrome. The median age at first fitting was 13 years (mean 12.3 years, range 4-17).
Over the 10-year period, all 32 BCHIs were performed as a singlestage surgery, in 22 patients, and by a single surgeon. In the majority of our cohort, no soft tissue reduction was undertaken. In older children, if any tissue reduction was required, this was performed minimally.
Ten additional patients were managed by a long-term "soft-band" bone conduction hearing device (BCHD). For these long-term softband users, their BCHD was first used at a median age of 5.5 years (mean 5.5; range 2-9). All ten soft-band users were female.
| Statistical analysis
Descriptive statistics were performed on demographic and outcome data.
| RESULTS
A total of 22 cases were identified and included in the analysis. All had undergone transcutaneous BCHI placement for hearing rehabilitation in COM. Five cases had previously required ipsilateral mastoid surgery. Follow-up data were available for all patients.
A total of 32 BCHI devices (Cochlear® BA300/BA400 series; Cochlear Bone Anchored Solutions AB, Mölnlycke, Sweden) were placed at primary surgery. All were performed as a single-stage procedure; 45.5% of patients received bilateral implants. Implant stability quotient (ISQ) was measured following fixture placement and recorded as satisfactory in all cases. Holgers scoring is an established method to record the degree of postoperative soft tissue inflammatory reaction (Table 1) . At the first-fitting appointment, occurring between 7 and 21 days, scores were 0 or 1 in 100%.
Cochlear® BAHA sound processors were loaded, with device used dependent on the time of fitting within the 10-year cohort (Divino, BP100, BAHA4; Cochlear Bone Anchored Solutions AB, Mölnlycke, Sweden). Loading was successfully undertaken at increasingly earlier intervals (range 7 days-3 months).
Keypoints
Paediatric bone conduction hearing implants are a safe, well-tolerated and reliable method of hearing rehabilitation in chronic otitis media.
Paediatric patients would be expected to grow; a higher volume of revision procedures, to address expected soft tissue problems, is expected in this cohort.
The rate of traumatically lost fixtures in our series mirrors data from the literature, with higher rates than in respective adult cohorts; this was especially evident in patients with learning disabilities. 
| Strengths of the study
This study is unique in that it reports the experience of paediatric cases receiving BCHI solely for COM. The experience in our unit highlights the importance of counselling parents and older children in their expectations and recognising the likelihood of additional surgeries during phases of growth; increasing the abutment length and soft tissue revisions both require a general anaesthetic in paediatric cases in contrast to greater tolerance of such procedures in adults.
| Comparisons with other studies
Within the literature, evidence is presented for cost-effectiveness, The parental-reported quality of life (Glasgow Childhood Benefit Inventory, GCBI) 3 and parental-reported functional measures (PEACH) are reported. 4 The GCBI is a general scale that has been developed for the paediatric population 3 and is derived from the adult Glasgow Benefit Inventory (GBI), which has been reported for BCHI. 5 It is not widely applied to BCHI patients; however, one retrospective study reports high satisfaction with the procedure reported by the postoperative GCBI 5 and despite a reporting significant revision surgery rate that is mirrored in the paediatric literature. 4, 6, 7 Similar rates of major and minor complications, relative to our data, are highlighted by the literature. These include up to 42% receiving treatment of peri-implant reactions and 15%-26% undergoing surgery for replacement of the implant and/or abutment. 4, [6] [7] [8] Such complications, specific to paediatric, include non-statistically significant higher rates reported in some cohorts, 7 but not others, 9 in learning difficulty patients. 7 This trend is reflected by those in our series; all patients with Down syndrome, and one patient with blindness, required revision surgery to replace their traumatically lost implants.
Whilst skin overgrowth has been reported to occur with equal frequency in adults and children, 10 revision procedures invariably place a greater burden on children who will require a further general anaesthetic-factors that are vital to discuss during the consent process for these patients. These are the two key points to emphasise when undertaking BCHI in children: firstly, they are more intolerant of soft tissue management and cleaning and thus 
